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ABSTRACT 
Previous investigations at the Falmouth Road Race (FRR; Falmouth, MA) suggest that 
combined exercise, heat, and dehydration stress increase circulating lipopolysaccharide, 
associated binding proteins, and downstream immune signaling. Lipopolysaccharide (LPS), a 
component of gram-negative bacterial membranes, may be released into circulation from the gut 
with increased gastrointestinal permeability observed post-exercise. Circulating LPS activates 
host immune cell signaling that can lead to inflammatory responses that upregulate pro-
inflammatory gene expression (eg TNF-α, IL-1β), which if unchecked, may lead to 
pathophysiology (eg cell pyroptosis, exertional heat stroke (EHS), and sepsis). While subjects of 
the 2015 FRR (n=30) had elevated core temperature post race (39.87°C) compared to pre 
(36.87°C, p<0.05), there is unexplained variation in the relationship among the level of 
circulating LPS (2.90±2.6EU/ml pre vs. 3.48±4.0EU/ml post, p<0.05; Hycult Biotech, ELISA), 
core temperature, and diagnosis of EHS or exertional heat illness. Since some strains of bacteria 
induce a strong immune response while others do not, we aimed to determine if structural 
variations in LPS contribute to varying immune system activation during exercise-heat stress. 
We utilized extraction of LPS from pre-race and post-race plasma and FTIR spectroscopy to 
characterize structural variations in LPS in individuals of the 2015 and 2017 FRR, and conclude 
that other methods of analysis may be appropriate to fully understanding this relationship. 
Acknowledging the diversity of circulating LPS will be critical to answering fundamental 
questions about EHS pathophysiology and the interaction between gut health and exercise in 
stressful environments, as this approach has never been taken to examine whether structural 
variants may explain some of the variability in literature around LPS post exercise and as a 
potential biomarker for EHS. 
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LITERATURE REVIEW 
Introduction 
 Current literature and our unpublished data suggest that exercise, heat, and dehydration 
stress increase gastrointestinal (GI) tract permeability, exposing the circulatory system to 
components of the microbiome usually found only in the gut. Lipopolysaccharide (LPS) is one 
such element leaked into circulation; circulating LPS activates host immune cell signaling 
cascades that can in extreme circumstances lead to cell pyroptosis, increased core temperature, 
heatstroke, and septic shock.  
I. Lipopolysaccharide characterization 
 LPS is a component of the outer membranes of gram-negative bacteria that contributes to 
structural integrity and defense of microorganisms (Qiao, 2014). Under normal conditions of the 
human gut, LPS is secreted from these membranes without the breakdown of the cell wall via 
bacterial outer membrane vesicles (Kulp, 2010). When a person is not physiologically stressed 
(ie the absence of heat or dehydration stress), there is little risk associated with this secretion. 
Released LPS remains within the gastrointestinal tract and is eventually expelled from the body. 
Separation of the GI tract and the bloodstream is maintained via tight junction proteins, 
mucous, chloride, and water secretions at gut epithelial cells (Lakhan, 2010). Under 
physiological stress, however, the integrity of this barrier can be compromised (Harris, 2012). 
Paracellular transport is the process by which LPS leaves the colon and enters the bloodstream 
through “leaky” tight junctions. LPS may then be responsible for host innate inflammatory 
responses (Harris, 2012).  
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i. Structural properties 
 LPS consists of two main components: a lipid and a polysaccharide. The polysaccharide 
portion is composed of two units: the O antigen and the core polysaccharides. The O-specific 
hydrophilic side chain has repeating oligosaccharide units that are specific to the bacterial 
species from which the molecule comes. This antigen portion is highly variable. The inner 
heptose and outer hexose polysaccharide cores are widely conserved across gram-negative 
bacteria and are attached to phosphate groups that act to stabilize the molecular structure. While 
the polysaccharide portion may not be present in all LPS variants, the hydrophobic lipid portion, 
termed lipid A, must be present for bacterial viability. Lipid A is responsible for the endotoxic 
effects of LPS (Rietschel, 1994). Variations in the structure of LPS can change the biological 
activity of the molecule and subsequent immune activation (Schletter, 1995). Because of these 
structural variations in LPS across bacteria, the molecular weight of the molecule ranges from 10 
to 20 kDa (Rietschel, 1994). 
 
Figure 1. General structure of LPS (Qiao, 2014) 
ii. Biochemical pathway 
 LPS activates myeloid lineage immune cells (specifically circulating macrophages) by a 
series of molecular interactions and pathways (Liu, 2007). The lipid A portion of LPS acts as a 
pathogen-associated molecular pattern that is recognized by LPS-binding protein (LBP), a 
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circulating acute-phase protein. LBP associates with LPS, and then the extracellular membrane 
bound protein CD14 recognizes the complex and presents it to MD-2. MD-2 is an extracellular 
adaptor protein that associates with Toll-like receptor 4 (TLR4). This association triggers 
homodimerization of TLR4 and subsequent signal transduction through intracellular cascades. 
TLR4 is a major component in the recognition of the molecular patterns associated with bacterial 
infections and specifically LPS by T cells (Liu, 2007). Intracellular Toll-interleukin-1 receptor 
(TIR) domains allow the TLR4 oligomer to recruit downstream adaptors, including MyD88, 
TIRAP, TRIF, TRAM and SARM (Pallson-McDermott, 2004).  
 
Figure 2. Representation of LPS signaling pathway (Lu, 2008) 
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 The entire complex of LPS-associated extracellular and intracellular proteins can utilize 
two separate pathways that have distinct outcomes for the cell: MyD88-dependent and MyD88-
independent (Chow, 1999). The MyD88-dependent pathway recruits death-domain containing 
IRAK molecules and TRAF6 adaptor proteins. Through a series of downstream phosphorylation 
events, NF-κB is activated. Ultimately, this pathway leads to the release of pro-inflammatory 
cytokines (eg TNF-α and IL-6) from immune cells that promote localized or systemic 
inflammation (Frost, 2002). The MyD88-independent pathway depends on TRIF adaptor 
proteins. TRIF recruits TRAF3, another adaptor protein, which activates IRF3 and NF-κB to 
induce Type 1 interferons (Lu, 2008). These two activation pathways have different 
consequences for immune cells and are dependent on the shape of the presented lipid (Rietschel, 
1994; Lu, 2008).  
iii. Immune system activation 
 Structural variations of LPS may lead to differential innate immune responses 
(Alexander, 2001). Pro-inflammatory cytokines, resulting from the MyD88-dependent TLR4 
pathway, can cause infected cells to swell, burst, and die. This form of cell death, pyroptosis, is a 
noncanonical response, which is dependent on the source bacteria of the LPS (Jorgensen, 2015). 
For example, Helicobacter pylori LPS stimulates the response poorly while Escherichia coli LPS 
produces a robust immune response (Kayagaki, 2013). While this pathway is important to an 
effective immune response to LPS, too much activation can lead to host inflammation. Similarly, 
Type 1 interferon, released upon activation of the MyD88-independent TLR4 pathway, is 
necessary for activating natural killer cells that destroy infected cells (Shi, 2014; Smith, 2015). In 
general, over-activation of the immune system can be harmful to the host. These responses 
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include but are not limited to inflammation, increased core temperature and fever, heatstroke, 
and endotoxic shock (Hagar, 2013). 
iv. Pro-inflammatory vs. anti-inflammatory responses 
 The best-characterized responses to LPS in circulation are pro-inflammatory. The 
subsequent release of pro-inflammatory cytokines and stress hormones may result in fatigue, 
mood changes, and underperformance (Clark, 2016). LPS can also activate circulating 
macrophages, cause gene expression changes, and lead to more serious pathologies such as 
endotoxemic shock, especially in people who consume high plant-based diets (Clark, 2016; 
Aung, 2005).  
 Anti-inflammatory LPS responses to exercise have been less well characterized and 
primarily in murine models. In vitro, LPS added exogenously to cultured macrophages leads to a 
robust immune response, including B cell and macrophage activation. However, when LPS is 
injected into live mice, an anti-inflammatory response is described. The response includes a 
decreased accumulation of macrophages when the injection is paired with another inflammatory 
stimulus for at least 72 hours, as compared to mice resistant to LPS. In the resistant strains, LPS 
exacerbates the immune response caused by another inflammatory stimulus (Verghese, 1981). 
This difference in response may be caused by many factors, including the difference between 
exogenous and endogenous LPS. 
v. Endogenous TLR4 agonists 
Although LPS is the major activator of TLR4 on immune cells (eg T cells, dendritic cells, 
macrophages), there are also other agonists that may activate the pro-inflammatory pathway in 
humans. Some of these include: heat shock proteins 60 and 70 (involved in protein folding and 
cellular stress resistance), resistin (involved in insulin resistance), and β-defensin (involved in 
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antimicrobial defense) (Erridge, 2012; Liu, 2007). LPS may not be solely responsible for TLR4-
induced inflammation post exercise, but not studies have investigated this possibility. 
vi. LPS isolation and structural characterization 
 LPS can be isolated from blood by introducing a polar solvent that interacts with the 
polysaccharide region of the molecule (Bernhardt, 1991; Rezania, 2011). In brief, plasma or 
serum samples, that have been stored at -80°C since, are thawed and then treated with excess 
methanol. After extraction, the supernatant can be analyzed for structural characterization (Zhao, 
2010). Some of the methods for characterizing the molecule include: nuclear magnetic resonance 
(NMR; Zahringer, 2014), mass spectrometry (Kilar, 2013), chromatography (de Barros, 2015), 
crystallography (Ferguson, 2000), and infrared spectroscopy (Brandenburg, 1993; Kim, 2005).  
Chromatography: There are several chromatographic methods that can be used to resolve 
molecular structure, including gel filtration and affinity chromatography. In general, 
chromatography separates proteins based on affinity to the solution they are dissolved in and a 
stationary phase. Unique variants should occupy distinct spaces along a chromatography plate, 
and reveal how many different structural variants of LPS are in circulation (Lodish, 2000). 
Mass spectrometry: Advances in mass spectrometry have made it an increasingly 
powerful tool to determine the covalent structure of proteins. The protein must be fractionated 
into ionized species, analyzed to determine the mass-to-charge ratio of each ion, and then 
compared to known to resolve the amino acid sequence. Structural properties of both pure and 
mixed solutions are determined by shifts in intensity and positions in the spectra (Domon, 2006).  
NMR: NMR can be used to determine two and three dimensional protein structure in a 
solution. This technique is best suited for proteins between 5 and 25 kDa. NMR measures nuclei 
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spin in a magnetic field, which is translated into signals that account for chemical shift, folding 
of a molecule, and the relationship of one atom to its neighbor (Poulsen, 2002).  
Crystallography: This method is especially useful for determining the three-dimensional 
structure of a protein. It requires concentrating and crystallizing the molecule and then using X-
rays to create an electron density map. This map can be translated into a resolved structure at the 
atomic level. Crystallography can also elude to functionality of a molecule (Lodish, 2000). 
High performance liquid chromatography mass spectrometry (HPLC-MS): Solutions of 
the compound of interest are added to a HPLC column packed with silica. Compounds separate 
based on interactions with the stationary phase (ie the silica) and the mobile phase (ie the solvent 
eluent). The eluted components are then analyzed with electrospray ionization or atmospheric 
pressure chemical ionization (Gates, 2018).  Extraction of LPS from plasma is necessary to 
perform this kind of analysis. 
Fourier transform infrared spectroscopy (FTIR): FTIR uses vibrational or rotational 
motions of functional groups on molecules to produce a series of absorbances over a spectrum of 
wavelengths. Functional group peaks are assigned to specific regions on the molecule according 
(Kim, 2004). Extraction of LPS from plasma is necessary to perform this kind of analysis.   
                            
Figure 3 (from Kim, 2005). Example of the output of FTIR from isolated LPS of Salmonella 
enterica serotypes. The numerical labels correspond to: fatty acid region (I), amide region (II), 
mixed region (III), polysaccharide region (IV), and fingerprint region (V). 
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II. The gut microbiome 
 
 The composition of the gut microbiome can indirectly influence immune responses. 
When the gut becomes leaky in response to increased core temperature, for example, 
components of the microbiome are released into systemic circulation (Sekirov, 2010). These 
components in circulation can then lead to differential pathophysiology, and we hypothesize, 
during or after exercise. 
i. Characterization of the microbiome 
 Under normal conditions, the gut is stably separated from its external environment by an 
intestinal barrier that is both physical and chemical. The physical barrier is cellular, and consists 
of vascular endothelium, epithelium, and mucosal cells. The chemical barrier consists of immune 
cells, digestive secretions, and cellular secretions such as cytokines and inflammatory mediators. 
Together these two layers help maintain balance for the body. They prevent water and electrolyte 
loss, allow nutrient absorption, and play an important immune function by preventing pathogens 
from entering the body through the gut. When the normal flux of molecules in and out of the gut 
is not functioning properly in equilibrium, systemic problems can arise, including metabolic 
diseases, neuropathologies, and sepsis (Bischoff, 2014). 
 Intestinal microbiota, normally contained within the gut, are mostly symbiotic with the 
host. Bacterial colonies in the gut tend to be very dense, up to 1012 bacteria per gram of intestinal 
luminal content. Individual guts typically have several hundred species of bacteria from two 
major phyla, with Bacteroidetes and Firmicutes making up 99% of the human gut (David, 2014). 
The microbiome plays a role in nutrient breakdown and absorption, the prevention of 
colonization by harmful pathogens, and vitamin production. This bacterial layer provides a third 
line of defense in the regulation of gut permeability (Fujimura, 2010).  
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ii. Dietary influences on the composition of the microbiome 
 The exact composition of the gut microbiome is largely dependent on diet. Of the two 
dominant bacterial phyla in the gut, those from Bacteroidetes become more prevalent in the gut 
in an individual who eats an animal-based diet because these bacteria are able to break down 
protein. In contrast, bacteria from the phyla Firmicutes, which are better suited to plant-
breakdown, dominate when an individual consumes a strictly plant-based diet. It has been known 
for some time that the composition of the microbiome can change on a long-term scale, but more 
recently, it has been demonstrated that due to diet, there can be dramatic, short-term changes that 
reflect a trade-off between protein and sugar fermentation. Taxonomic shifts can be observed in 
as few as 3 days after diet modification (Heiman, 2016). Changes in diet not only influence the 
community structures of microorganisms in the gut, but can also change the gene expression 
patterns of the microbes (David, 2014; Lloyd-Price, 2016). 
iii. Role in immune responses 
 Much like LPS in circulation can activate immune cascades, intestinal bacteria can 
activate inflammasomes and proinflammatory cytokines within the gut. These cascade products 
are necessary for the immune system because they defend the host from intestinal pathogens. 
This has been demonstrated in germ-free mice through the use of antibiotics: when antibiotics 
obstruct the microbiome of the host, fewer inflammasomes are produced in response to 
pathogens and so the host is more likely to develop metabolic pathologies (Round, 2009). 
Furthermore, disruptions to the normal functioning of the microbiome can lead to autoimmunity, 
allergies, and cancer because the bacterial colonies of the gut play a large role in the 
development of the adaptive immune system which normally defends the body from such 
diseases (Sekirov, 2010; Fujimura, 2010).  
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The composition of the microbiome is constantly changing, which suggests a reason for 
why people are better able to fight infections at certain points in their lives (Chen, 2016). 
Specific key species of microbiota elicit responses necessary for overall health and homeostasis. 
Without those key species, as a result of diet, drug or alcohol use, as well as other environmental 
factors, people become vulnerable to infections and diseases (Bischoff, 2014). The role of the 
microbiome in systemic immune responses is not completely understood, but it is clear healthy 
and diseased states in mammals are largely influenced by the gut’s microbial composition. 
iv. Microbiome changes as a function of aging 
 Aging is associated with changes to the gut microbiome in terms of composition and 
stability. Specifically, it has been reported that aging comes with enrichment in Proteobacteria, a 
group containing bacteria that are known to cause pathology. It has also been noted that an aged 
microbiome is associated with a decrease in genes for short-chain fatty acid production and loss 
of saccharolytic potential, in addition to changes in circulating inflammatory cytokines (eg IL-6 
and IL-8). In people over 70 years old, there is loss of microbial diversity, but there is little 
predictive power for these changes because of other systemic age associated changes, including 
changes in diet and physical activity and an overall increase in chronic inflammation (Buford, 
2017). 
 Some of the changes to the microbiome associated with aging are related to a typical 
western diet, which tends to be rich in high saturated fats and sugars. Over time, too much fat 
and sugar lead to depletion of microbial diversity and an increase in chronic inflammatory 
disorders (Buford, 2017). In addition, nutrient absorption decreases with deterioration of salivary 
function and digestion. Taken with chronic activation of the immune system, the gut becomes 
especially vulnerable to rapid composition changes with increasing age (Buford, 2017). 
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III. Exercise in the heat 
 Exercise in stressful environments and under conditions, like hypohydration, that increase 
physiological stress, impacts gut physiology. In part due to induction of gut leakiness, exercise in 
the heat can lead to an unsafely elevated core temperature, heatstroke, and septic shock. While 
altering the composition of the gut microbiome may be able to mitigate some of the risk of these 
extreme pathologies, there are currently few recommendations in the literature on how to 
accomplish this and whether this is even a possibility. 
i. Exercise as an inducer of gut leakiness 
Under non-stressful conditions, the gut is isolated from the rest of the body by tight 
junctions between intestinal epithelium cells (Lamprecht, 2012). There are many factors that can 
alter the integrity of these tight junctions, such as taking aspirin. While the barrier is typically 
tightly regulated, it does not take much to alter the balance and increase permeability to the 
outside environment (Farhadi, 2008). A leaky gut is also thought to be responsible for several 
autoimmune diseases, such as rheumatoid arthritis and inflammatory bowel disease, and central 
nervous system dysfunctions including anxiety and depression (Julio-Pieper, 2016). When the 
body is exposed to high levels of inflammatory elements from the gut, there can be a systemic 
response, as evidenced by the occurrence of seemingly unrelated diseases.  
 Research suggests that exercise, particularly in heat, can lead to an increase in gut 
leakiness (Lamprecht, 2012). Athletes who exercise strenuously are susceptible to cramps, blood 
in the stool, nausea, and bloating because of decreased tight junction functioning (Lamprecht, 
2012). This causes immune cells to be exposed to pathogens normally contained within the gut, 
and thus an immune response to be induced (Lamprecht, 2012). While intense exercise can be 
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harmful, it is worth noting that moderate exercise can have an anti-inflammatory response, 
especially in aged people (Karper, 2011).  
ii. Immune system activation   
 Exercise in the heat can negatively affect exercise performance by impacting endurance 
and metabolic and/or cardiovascular responses (Vargas, 2016). With increasing core 
temperature, the autonomic nervous system responds by diverting blood from the core and 
toward peripheral circulation to increase evaporative cooling (Sawka, 1993). This diversion is 
associated with increases in GI leakiness and subsequent presence of LPS in circulation post-
exercise as the intestinal barrier dysfunctions (Lambert, 2008). If too much LPS enters systemic 
circulation, there is potential for the development of sepsis, heat stroke, and even death 
(Bosenberg, 1985). For most people, there is only a mild immune response to elevated LPS, but 
depending on the type, intensity, and duration of exercise, a prolonged inflammatory response 
may be elicited and result in these pathophysiologies (Ziemann, 2013). 
iii. Long and short term effects 
 In the short-term, LPS induces an acute phase inflammatory response in individuals who 
exercise in the heat. The response is varied, however. In some, core temperature remains in a 
safe range and there is no central nervous system dysfunction. Others may develop exertional 
heat illnesses after engaging in the same type and intensity of exercise. The expression of protein 
biomarkers for exercise-induced heat stress (eg interleukin-6, heat shock protein 72, 
immunoglobulin M) may become elevated during exercise and for a short amount of time post 
exercise (Barberio, 2015). 
Acclimation to exercise in hot and humid environments may reduce intestinal 
permeability and minimize the presence of LPS in circulation (Guy, 2016). Additionally, the 
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extent to which biomarkers of heat illness are expressed can be reduced with training (Barberio, 
2015). The LPS self-immunization theory suggests that repeated bouts of exercise in the heat can 
have protective effects. People with chronic low-grade LPS in circulation can develop a 
tolerance to LPS and thus to exercise-heat stress (Armstrong, 2018). Alternately, others with 
chronic LPS in circulation may develop pathologies, including diabetes, kidney disease, and 
obesity (Glaros, 2013; McIntyre, 2010). It is unclear where the distinction lies between 
protective and detrimental effects of chronic LPS in circulation. 
Conclusion 
 Exercise in the heat can lead to a wide variety of systemic responses. These reactions are 
influenced largely by an individual’s fitness level, gut microbiome composition, and pre-existing 
conditions. When the gut becomes leaky post-exercise in the heat, LPS is released into 
circulation. While low levels of LPS are not necessarily harmful, elevated concentrations in the 
blood can lead to extreme pathologies like septic shock. It has been suggested in the literature 
that the source bacteria from which the LPS came can determine the severity of the immune 
response, which leads to the conclusion that there must be structural variations that account for 
these differences. Determining exactly what the structural variations exist will elucidate how 
LPS responds to exercise-heat stress.  
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METHODS 
Subjects 
 Participants of Falmouth Road Race (2017) were recruited to assess and identify genetic 
and cellular risk factors for exertional heat illness during summer road races. 32 participants (19 
males; age, 45.03±11.62 y; body mass, 73.95±13.65 kg; height, 174.78±9.21 cm; maximal 
aerobic capacity, 40.45±6.81 mlkg-1min-1) consented to participate. Study inclusion criteria 
included: no chronic health problems, no history of cardiovascular, metabolic or respiratory 
disease, no fever or other illness at the time of the race, no gastrointestinal motility disorders, no 
experience of syncope during exercise, no family history of malignant hypothermia, no problems 
with anesthesia, and predicted to finish the race in under 60 minutes. All subjects were briefed 
and provided informed consent. This study was approved by the University of Connecticut 
Institutional Review Board.  
 Between late July and early August 2017, participants were asked to visit the Human 
Performance Laboratory at the University of Connecticut to complete a maximum oxygen 
consumption test (VO2max) and a 7.1-mile run test. Body composition, height, body weight, heart 
rate, urine specific gravity and urine color, and rectal temperature were measured during this 
visit. On the night before the race, participants ingested a gastrointestinal temperature pill to 
monitor core temperature via a CoreTemp ELITE device attached to a waist strap during the 
race.  
Race day measures and analysis 
On race day (August 20, 2017), subjects reported to a research tent for pre-race and post-
race: physiological measurements (eg body mass, urine specific gravity), and blood and urine 
samples collection. Urine was analyzed for specific gravity and color on site and discarded. 21 
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mL of whole blood was collected from the antecubital fossa veins into serum, EDTA-plasma, 
and sodium-heparinized cell preparation plasma (CPT) vacutainers by trained phlebotomists. 
Vacutainers were centrifuged for 15 minutes at 1800 g and 4°C (Eppendorf, Centrifuge 5810 R, 
15-amp version, Hamburg, Germany) and aliquoted on site.  
EDTA and sodium-heparinized plasma samples were stored in 1 mL aliquots on dry ice 
and then transferred to a -80°C freezer (-80C Low Temperature Freezer, Thermo Electron 
Corporation, Model 8607, Marietta, OH) within 18 hours of collection. Peripheral blood 
mononuclear cells (PBMCs) were aliquoted from CPT vacutainers and stained with fluor-
conjugated antibodies on site. In brief, PBMCs were centrifuged at 200 g for 5 minutes at 4°C, 
washed and fixed in 1x phosphate buffered saline (PBS)/0.5% bovine serum albumin 
(BSA)/1.6% paraformaldehyde, and then stained with 1x PBS/0.5% BSA and CD14-FITC, 
CD16-PECy7, and CD284-PE antibodies for 30 minutes. After a final wash in 1x PBS/0.5% 
BSA, cells were resuspended in 1x PBS/0.5% BSA, and analyzed via flow cytometry (Accuri C6 
Flow Cytometer, C Sampler) on site within 12 hours of staining. 
Biochemical analyses 
 LPS and LPS-binding protein (LBP) concentrations in EDTA-plasma samples were 
determined in duplicate by ELISA (Hycult Biotech, Uden, The Netherlands). LPS samples were 
heat-shocked at 37°C for 5 minutes to eliminate endotoxin-inactivating factors and were 
incubated at room temperature for at least 30 minutes prior to absorbance measurements. LBP 
samples were diluted 500-fold according to kit recommendations. Both LPS and LBP absorbance 
measurements were determined on a Versamax tunable microplate reader (Molecular Devices, 
Sunnyvale, CA) at the wavelength indicated by each kit. Circulating inflammatory cytokines (IL-
8, IL-1β, IL-6, IL-10, TNF, and IL-12p70) concentrations were measured using a cytometric 
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bead array (BD Biosciences, San Jose, CA, USA) with EDTA-plasma samples and analyzed via 
flow cytometry. Concentrations of heat shock proteins 90, 60, 27, and 70 in plasma were 
measured in duplicate by ELISA (StressMarq Biosciences, Victoria, British Columbia) according 
to kit instructions.  
 For structural variant determination, LPS was isolated from EDTA-plasma samples and 
analyzed via attenuated total reflection-Fourier transform infrared spectroscopy (FTIR; Nicolet 
Magna IR-560 with OMNIC software, Nicolet Instrument Corporation, Madison, WI) and high 
performance liquid chromatography/mass spectrometry (Synapt G2-Si, Waters Corporation, 
Milford, MA). For isolation of LPS from plasma, the “methanol method” was used (Zhao, 2010). 
Samples were added to 100% methanol, vortexed, and incubated on ice for 10 minutes. After 
centrifugation (5 minutes, 10,000 g, room temperature), supernatant was transferred to a new 
tube and kept on ice until FTIR analysis.  
 FTIR analysis was optimized by varying concentration of plasma to methanol (1:0 (a), 
1:5 (b), 1:10 (c), 1:15 (d)) to determine which resulted in the least solvent interference (Figure 
4). Based on the scans, 1:5 dilution was used for further analysis. Background was collected 
before each run and 10 µL of sample was added to the instrument for analysis. 128 scans were 
performed at 4.000 cm-1 with units of absorbance over the spectrum 4000-400 cm-1.  Analysis of 
structural variance was performed by isolating the peak(s) in the spectra corresponding to the 
polysaccharide region of LPS, between ~1070 cm-1 and ~1170 cm-1. Exact regions were isolated 
by points of inflection in the curves using CSV output from the FTIR instrument. Areas under 
the curve approximations were determined by summing partial squares over the entire relevant 
wavelength for the plots wavelength vs. absorbance. Linear regressions models were created for 
pre and post area under the relevant curve vs. post race core temperature of each participant. 
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Figure 4. FTIR optimization spectrum with 32 scans.  
Statistical analysis 
 All data were analyzed using SAS version 9.4 (SAS Institute, Inc., USA). Two tailed 
paired t-tests were used for pre and post race comparisons of USG, core temperature, body mass, 
TLR4 MFI on CD14 and CD16 cells, circulating [LBP], circulating [LPS], and circulating 
[HSP60]. Linear regression analysis was used to determine the relationship between FTIR 
absorbance values in the polysaccharide region of the spectra and post race core temperature. 
Significance level was set at p<0.05 for all variables and comparisons, and all data are presented 
as mean ± standard deviation. 
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RESULTS 
Participants 
32 participants (19 males; age, 45.03±11.62 yrs; body mass, 73.95±13.65 kg; height, 
174.78±9.21 cm; maximal aerobic capacity (VO2max), 40.45±6.81 ml/kg/min) completed baseline 
and race day measures and testing at the 2017 Falmouth Road Race. VO2max was assessed within 
1 month of race day (July 23, 2017-August 5, 2017) to establish baselines aerobic capacity of all 
participants. Pre-race minimal clothing body mass, urine specific gravity (USG), and blood 
draws were completed within 4 hours of the start of the race (collection occurred 5:00-7:00 am; 
race began at 9:00 am). Post-race minimal clothing body mass, USG, and blood draws were 
completed within 1 hour of each subject’s individual finish time (course closed by race officials 
at 11:30 am). Core body temperature was continuously monitored during the race via an 
ingestible thermistor. Significant differences (p<0.05) were found in core temperature (elevated 
post race) and body mass (decreased post race) but not in USG, suggesting dehydration stress 
was mitigated by pre-race euhydration or ad libitum fluid intake during the race (Table 1). 
TLR4 activation, LPS, and LBP activity 
 Data are presented for 2015 FRR and FRR 2017 for comparison across the years due to 
differences in environmental conditions (temperaure2015, 84°F; temperature2017, 72°F). TLR4 
activation was measured via fluor-conjugated antibody staining on CD14+ cells and CD16+ 
cells. No significant difference (p>0.05) pre vs. post of mean fluorescence intensity (MFI) of 
TLR4 expression on CD14+ cells for 2017 subjects, but a significant increase in MFI was 
observed in 2015 subjects in post and recovery (30-60 minutes after finishing the race) samples 
(Figure 5). Significant increase (p<0.05) pre vs. post of mean fluorescence intensity of TLR4 
expression was observed on CD16+ cells in 2017 and 2015. MFI also significantly increased vs. 
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pre in recovery samples in 2015 (Figure 6). Concentration of circulating LPS binding protein 
was not significantly different (p>0.05) pre vs. post in 2015 or 2017 samples, or in recovery 
samples in 2015 (Figure 7). Concentration of circulating plasma LPS was not significantly 
different (p>0.05) pre vs. post in 2017. In 2015, however, significant increases in circulating LPS 
in pre vs. post and recovery samples were measured (Figure 8). Concentration of circulating HSP 
60, an endogenous ligand of TLR4, was not significantly altered pre vs. post race in 2017 (Figure 
9). 
LPS structural analyses 
 Resolution was not high enough to elucidate structural variation in the polysaccharide 
region of LPS using only 32 scans on the FTIR instrument (Figure 10).  Therefore, 128 scans 
were used for all data collection, as it was possible to visualize and quantify shifts in absorbance 
peaks at that higher resolution (Figure 11). Linear regression analysis of FTIR spectra for pre and 
post-race samples (FRR 2015 and FRR 2017) revealed no significant correlations between LPS 
variants and post-race core temperature (Figure 12, Table 2).   
Variable Mean (±SD) Significantly different pre 
vs. post 
Age 45.03 (11.62) N/A 
Height (cm) 174.78 (9.21) N/A 
VO2max (ml/kg/min) 40.45 (6.81) N/A 
VO2max heart rate (bpm) 170.71 (9.56) N/A 
USG pre 1.015 (0.007) N/A 
USG post 1.013 (0.016) No, p=0.53 
Core temperature pre (°C) 37.13 (0.534)  N/A 
Core temperature post (°C) 39.44 (0.904) Yes, p<0.001 
Pre-race body mass (kg) 73.7 (14.0) N/A 
Post-race body mass (kg) 72.4 (13.7) Yes, p<0.001 
Table 1. Baseline and race-day variables for 2017 FRR participants 
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Figure 5. TLR4 MFI on CD14+ cells 
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Figure 6. TLR4 MFI on CD16+ cells  
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Figure 7. Concentration of circulating LBP 
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Figure 8. Concentration of circulating LPS 
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Figure 9. Concentration of circulating HSP60 
 
 
 
 
Figure 10. Example of post sample FTIR spectra with 32 scans 
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Figure 11. Examples of pre and post FTIR spectra with 128 scans 
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 Analysis of Variance Parameter Estimates R2 
Samples F value Pr > F Parameter 
Estimate 
t Value Pr > |t|  
Pre 2015 0.10 0.7560 0.16974 0.32 0.7560 0.0084 
Post 2015 0.28 0.6042 0.29779 0.53 0.6042 0.0231 
Pre 2017 1.15 0.3086 -0.5432 -1.07 0.3086 0.1032 
Post 2017 0.12 0.7346 -0.15891 -0.35 0.7346 0.0120 
 
Figure 12/Table 2. Linear regression models of pre (top (2015) and bottom (2017) left) or post 
(top (2015) and bottom (2017) right) FTIR absorbance values vs. post core temperature with 
table of analysis of variance and parameter estimates for each regression model 
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DISCUSSION 
Differences in the absolute values and levels of significance in measured variables 
between FRR 2015 and FRR 2017 are likely in part due to environmental conditions. Maximum 
temperature in 2015 was 84°F with 100% humidity, while it was only 72°F with 100% humidity 
in 2017. It has been noted in mammals that environmental conditions contribute to the 
inflammatory response after LPS-challenge. Under hypothermic conditions, activation of innate 
immune cells is lower than under thermoneutral conditions. Furthermore, the immune response is 
more increased under hyperthermic environmental conditions compared to thermoneutral 
conditions (Carroll, 2011). These inconsistencies in environmental temperature across the years 
suggest a potential explanation for the values we observed. Differences in our subject 
populations across the years may also be partly responsible for the inconsistency in absolute 
values of LPS, LBP, and TLR4 expression. Standard values of LPS in circulation pre or post 
exercise have not been set, to date, because LPS release is dependent on too many factors: the 
type, intensity, and duration of exercise, environmental conditions, and the level of training of 
each individual (Barberio, 2015). Thus, it would be worth investigating the training levels across 
the years to determine if in 2017, the runners were more highly trained, and therefore more 
resistant to inflammatory responses post-exercise than those in 2015.  
 Similar to our results, Lichte et al. observed that a low dose of LPS (4 ngkg-1) does not 
increase TLR4 expression on CD14+ cells, even if there is an inflammatory response (Lichte, 
2013). In FRR 2015, TLR4 expression on CD14+ cells significantly increased pre vs. post, but 
so did the concentration of circulating LPS. The absolute values of LPS in circulation were also 
higher in 2015 compared to those in 2017. In FRR 2017, however, LPS in circulation did not 
significantly increase post race, and neither did TLR4 expression on CD14+ cells. Amounts of 
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LPS and TLR4 expression on CD14+ cells are highly associated with each other; as one 
increases in absolute value, so does the other (Lichte, 2013). Expression of TLR4 on CD16+ 
increased pre vs. post in both 2015 and 2017, however. This is reasonable since CD16+ 
monocytes are implicated specifically in inflamed states, sepsis, and bacteremia (Nagasawa, 
2004). Even very low does of LPS in circulation will increase TLR4 expression on CD16+ cells 
(Rennert, 2016). Since our participants had undergone a stressful bout of exercise immediately 
prior to the blood draws, we would expect that CD16+ TLR4 expression would be increased pre 
to post and to a greater extent than on CD14+ cells. 
 Circulating LPS binding protein (LBP) remained unchanged pre vs. post exercise in FRR 
2015 and FRR 2017. We observed similar results to those reported by McLellan et al. In their 
exertional heat stress model, they found that in trained individuals, over a range of rectal 
temperatures between 36.9°C and 39.5°C, there was no change in serum LBP values, even 
though after 39.0°C, plasma LPS began to significantly increase (McLellan, 2009). Participants 
in FRR 2015 and FRR 2017 reported being trained to the point where they predicted finishing 
the 7.1-mile race in less than 60 minutes. It therefore is reasonable that we observed no 
differences in pre vs. post circulating LBP concentrations in our participants, as they self-
reported being trained individuals. 
 While there are several endogenous ligands of TLR4, it is of note that circulating HSP60 
concentrations did not change pre vs. post race. HSP60 is a host-derived damage-associated 
molecular pattern, released into circulation in response to cellular stress. It is associated with 
inflammation and may contribute to central nervous system dysfunction that is hallmark of 
exertional heat stroke when it binds to TLRs (Rosenberger, 2014). Because we observed no 
change pre vs. post in circulating HSP60, it is likely that the activation of TLR4 was not due to 
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this specific molecule. We can, therefore, predict the effect of LPS played a role in the 
inflammatory responses we observe, although there may be other endogenous implicated in these 
responses (Erridge, 2010).  
 Our results suggest that FTIR spectroscopy is an appropriate tool to visualize and 
quantify variations in circulating LPS. However, due to several limitations of the instrument, it is 
necessary to pursue further structural analysis techniques before drawing any conclusions. Doing 
so will allow us to quantify relative abundances of each variant and potentially understand the 
three-dimensional structure of the molecule. As binding of receptors is dependent on specific 
confirmation of molecules, we should understand the shape of each variant as well to fully 
understand immune reactions to LPS post-exercise. It may also be useful to collect more direct 
samples for comparison to the blood samples we have analyzed. While blood is more readily 
available in a field setting, it would be important to have validation that the LPS in circulation is 
representative of the types of bacteria found in the gut.  
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FUTURE DIRECTIONS 
 
 The aim of this project was to determine if structural variations in circulating LPS can 
alter presentations of hyperthermia or heat stroke pathophysiology post race. In order to have 
predictive power in the future, continuing analysis is necessary to more completely qualify 
structure and quantify relative concentrations of each LPS variant. These goals will be 
accomplished in several ways, as outlined below: 
1. Continued FTIR analysis with pre and post overlay of all subjects. By analyzing all 
samples in a single spectral overlay, we will be able to directly compare structures for the 
entire group of interest. We may be able to more accurately detect patterns in variation 
and confidently quantify functional group variation in the polysaccharide region of LPS. 
It is also necessary to run replicates of each sample and average the spectra (available in 
the FTIR software) to ensure changes in room pressure, temperature, or airflow are not 
contributing to any variation in the output. 
2. HPLC/MS analysis. Literature reports that this method is a preferred way to quantify 
relative abundance of each LPS structural variant in plasma samples. Because the 
concentrations of LPS in each sample is relatively low, especially in the 2017 cohort, it 
may be necessary to concentration the molecule in the samples, which will require 
optimization trials before analysis. 
3. Diet composition analysis with correlation to core temperature. Literature suggests that 
gut microbial composition rapidly changes with diet. Therefore, what each subject 
consumed in the three days leading up to the race (data available but not represented in 
this thesis) may be a factor contributing to post race core temperature and exertional heat 
stress/stroke presentation. By understanding carbohydrate composition, specifically, we 
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can make estimates of bacterial species within the gut and better pro- vs. anti-
inflammatory LPS in circulation. 
4. Age as a covariate of inflammation. As age is associated with changes to gut microbiome 
composition toward pro-inflammatory species, it is necessary to introduce age as a 
covariate in the analysis. Having this variable will give a more complete understanding to 
the variations not only in LPS structure but also the inflammatory responses in 
individuals.  
5. Other endogenous TLR4 ligands. It is necessary to rule out other endogenous TLR4 
ligands as activators of TLR4 and subsequent inflammation presentations. While our goal 
is to determine if LPS variation contributes to exertional heat stroke pathophysiology, we 
must be confident that other molecules entirely are not responsible for activating the 
TLR4 pathway and causing immune reactions including increased core temperature and 
inflammation post exercise.  
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CONCLUSION 
Structural variations of circulating LPS characterized utilizing FTIR spectroscopy pre or 
post a 7.1-mile race in a hot and humid environment were not predictive of core temperature post 
race. There appeared to be changes in the polysaccharide regions between samples of the same 
subject (pre vs. post) and across all subjects, suggesting that FTIR spectroscopy may be a novel 
method to analyze LPS in circulation. It is necessary to repeat analysis with other techniques (eg 
HPLC/MS) to quantify relative abundance of each structural variant in circulation. More direct 
measures, including fecal sample analysis, may also be more appropriate to fully understand the 
variants of LPS that exist within a runner’s gut. Further investigation of exercise-induce gut 
permeability and the significance of LPS in post race pathophysiological outcomes is needed to 
completely understand the mechanisms that underlie exertional heat stress, exertional heat 
stroke, and exercise-induced endotoxemia. 
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